Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutritive Value Claim Disclaimer Undermines Consumer Confidence - Perrigo

This article was originally published in The Tan Sheet

Executive Summary

Requiring the DSHEA disclaimer on dietary supplements making nutritive valued-based structure/function claims would dissuade consumers from buying products that provide significant, well-recognized health benefits, Perrigo tells FDA.

You may also be interested in...



Structure/Function Claim Nutritive Value Debate Reopened By FDA

FDA is seeking feedback on both its current regulatory approach to dietary supplement products bearing nutritive value-based structure/function claims and the potential impact of a policy reversal on the issue.

Supplement/Disease Claim Continuum Suggested By CHPA

FDA acceptance of disease-treatment health claims and subsequent revision of the term "nutritive value" to reflect a dietary supplement ingredient's ability to restore normal/proper function is urged by the Consumer Healthcare Products Association.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel